Marty C, Misset B, Tamion F, Fitting C, Carlet J, Cavaillon J M
Immuno-Allergy Unit, Pasteur Institute, Paris, France.
Crit Care Med. 1994 Apr;22(4):673-9. doi: 10.1097/00003246-199404000-00025.
Interleukin (IL)-8, a pro-inflammatory cytokine, is a potent chemoattractant factor and an activator of neutrophils produced by many cell types after stimulation by IL-1, tumor necrosis factor (TNF), or microbial products such as endotoxins. We investigated whether the presence of measurable IL-8 in plasma was associated with the clinical status of severely ill septic or nonseptic patients susceptible to the development of multiple organ failure.
Cohort study.
A collaborative study between an intensive care unit and a research laboratory.
Circulating IL-8 concentrations were measured in the plasma of 27 patients with sepsis syndrome and in 16 patients with noninfectious shock because these two conditions put patients at risk for the development of multiple organ failure. Sixteen of 27 patients with severe infection and 13 of 16 patients with noninfectious pathologies developed multiple organ failure.
A specific enzyme-linked immunosorbent assay (ELISA) for IL-8 was set up with a monoclonal and a rabbit polyclonal antihuman IL-8 using a sandwich technique. High concentrations of circulating IL-8 were found in the plasma of patients with sepsis syndrome. Among septic patients, a significant difference was observed between concentrations of IL-8 in survivors (n = 16) and nonsurvivors (n = 11) (81 +/- 13 pg/mL vs. 3326 +/- 1219 pg/mL, respectively; p = .001). A correlation was noticed between plasma IL-8 and IL-6 concentrations (r2 = .42; p = .001), while no correlation was observed between IL-8 and TNF-alpha values, or between IL-8 and IL-1 beta. Although the mortality rate of nonseptic, multiple organ failure patients was 92%, low plasma concentrations of IL-8 were found (78 +/- 34 pg/mL), while high plasma concentrations were measured in septic, multiple organ failure patients (mortality rate 69%) who were sampled at a similar stage. By contrast, increased IL-6 values were observed in both septic and nonseptic, multiple organ failure patients.
In septic patients, high amounts of circulating IL-8 concentrations correlate with fatal outcome, whereas only low plasma concentrations of IL-8 are present in patients with nonseptic, multiple organ failure. This finding suggests that the signals involved in the exacerbation of IL-8 production are different, depending on infectious or noninfectious etiology.
白细胞介素(IL)-8是一种促炎细胞因子,是一种有效的趋化因子,也是许多细胞类型在受到IL-1、肿瘤坏死因子(TNF)或微生物产物(如内毒素)刺激后产生的中性粒细胞激活剂。我们研究了血浆中可测量的IL-8的存在是否与易发生多器官功能衰竭的重症脓毒症或非脓毒症患者的临床状况相关。
队列研究。
重症监护病房与研究实验室之间的合作研究。
在27例脓毒症综合征患者和16例非感染性休克患者的血浆中测量循环IL-8浓度,因为这两种情况使患者有发生多器官功能衰竭的风险。27例严重感染患者中有16例,16例非感染性疾病患者中有13例发生了多器官功能衰竭。
采用夹心技术,用单克隆和兔多克隆抗人IL-8建立了一种特异性的IL-8酶联免疫吸附测定(ELISA)法。脓毒症综合征患者血浆中发现高浓度的循环IL-8。在脓毒症患者中,幸存者(n = 16)和非幸存者(n = 11)的IL-8浓度存在显著差异(分别为81±13 pg/mL和3326±1219 pg/mL;p = .001)。血浆IL-8与IL-6浓度之间存在相关性(r2 = .42;p = .001),而IL-8与TNF-α值之间或IL-8与IL-1β之间未观察到相关性。虽然非脓毒症多器官功能衰竭患者的死亡率为92%,但血浆IL-8浓度较低(78±34 pg/mL),而在脓毒症多器官功能衰竭患者(死亡率69%)处于相似阶段时测量到的血浆浓度较高。相比之下,脓毒症和非脓毒症多器官功能衰竭患者的IL-6值均升高。
在脓毒症患者中,高循环IL-8浓度与致命结局相关,而非脓毒症多器官功能衰竭患者血浆中仅存在低浓度的IL-8。这一发现表明,根据感染性或非感染性病因,参与IL-8产生加剧的信号是不同的。